SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-161807
Filing Date
2022-05-27
Accepted
2022-05-27 09:11:58
Documents
17
Period of Report
2022-05-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d273651d8k.htm   iXBRL 8-K 56702
2 EX-3.1 d273651dex31.htm EX-3.1 293585
3 EX-4.1 d273651dex41.htm EX-4.1 964290
4 EX-99.1 d273651dex991.htm EX-99.1 9160
8 GRAPHIC g273651g67z57.jpg GRAPHIC 2975
9 GRAPHIC g323352g0527025337687.jpg GRAPHIC 7981
  Complete submission text file 0001193125-22-161807.txt   1734372

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA ocdx-20220527.xsd EX-101.SCH 2863
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE ocdx-20220527_lab.xml EX-101.LAB 17981
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ocdx-20220527_pre.xml EX-101.PRE 11263
11 EXTRACTED XBRL INSTANCE DOCUMENT d273651d8k_htm.xml XML 3440
Mailing Address 1001 ROUTE 202 RARITAN NJ 08869
Business Address 1001 ROUTE 202 RARITAN NJ 08869 (908) 218-8000
Ortho Clinical Diagnostics Holdings plc (Filer) CIK: 0001828443 (see all company filings)

IRS No.: 981151819 | State of Incorp.: X0 | Fiscal Year End: 0102
Type: 8-K | Act: 34 | File No.: 001-39956 | Film No.: 22972844
SIC: 2835 In Vitro & In Vivo Diagnostic Substances